yin qishuang

Mr. yin qishuang

Lanzhou University, Lanzhou, Gansu, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Cells
Verified
Journal Article
Open access
PDF file
NXniu xiaxia
niu xiaxia
TWTing Wu
Ting Wu
YQyin qishuang
yin qishuang
XGXinsheng Gu
Xinsheng Gu
GLGege Li
Gege Li
HCHongmei Cui
Hongmei Cui
Paclitaxel (PTX) is one of the most efficient drugs for late-stage non-small cell lung cancer (NSCLC) patients. However, most patients gradually develop resistance to PTX with long-term treatments. The identification of new strategies to reverse PTX resistance in NSCLC is crucially important for the treatment. PTX is an agonist for the pregnane X receptor (PXR) which regulates PTX metabolism. Antagonizing PXR, therefore, may render the NSCLC more sensitive to the PTX treatment. In this study, we investigated the PXR antagonist SPA70 and its role in PTX treatment of NSCLC. In vitro, SPA70 and PTX synergistically inhibited cell growth, migration and invasion in both paclitaxel-sensitive and paclitaxel-resistant A549 and H460 lung cancer cells. Mechanistically, we found PTX and SPA70 cotreatment disassociated PXR from ABCB1 (MDR1, P-gp) promoter, thus inhibiting P-gp expression. Furthermore, the combination regimen synergistically enhanced the interaction between PXR and Tip60, which abrogated Tip60-mediated α-tubulin acetylation, leading to mitosis defect, S-phase arrest and necroptosis/apoptosis. Combination of PXT and SPA70 dramatically inhibited tumor growth in a paclitaxel-resistant A549/TR xenograft tumor model. Taken together, we showed that SPA70 reduced the paclitaxel resistance of NSCLC. The combination regimen of PTX and SPA70 could be potential novel candidates for the treatment of taxane-resistant lung cancer.

26 August 2024 in Chinese Journal of Chemistry
Verified
Journal Article
Closed access
XLXin Lv
Xin Lv
JLJin‐Xi Liao
Jin‐Xi Liao
ZLZhen‐Qiang Li
Zhen‐Qiang Li
ZXZhi‐Sheng Xiong
Zhi‐Sheng Xiong
YQyin qishuang
yin qishuang
JSJian‐Song Sun
Jian‐Song Sun